In these ultra-hypermuted tumor cases, a secondary somatic event such as an inactivating mutation in POLE or POLD1 genes is considered to be responsible for the mutation burst(s) leading to the ultra-hypermutated phenotype. This evidence concerns the gene POLD1 and neoplasm.